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Abstract. To date, conventional and/or novel histamine 
receptors (HRs) have not been investigated in mouse skeletal 
myogenesis. Therefore, the present study aimed to investigate 
the HR-subtypes in skeletal myogenesis. The myogenesis 
of C2C12 skeletal myoblasts was evaluated using desmin, 
myogenin and myosin heavy chain (Myh) as early, interme-
diate and late differentiation markers, respectively. Reverse 
transcription-quantitative polymerase chain reaction and 
immunostaining were performed and the messenger RNA 
(mRNA) expression levels of the HR-subtypes and markers 
were determined. H1R mRNA was found to be highly expressed 
in myoblasts at day 0; however, the expression levels were 
reduced as differentiation progressed. By contrast, H2R mRNA 
expression remained constant, while H3R mRNA expression 
increased by 28-, 103- and 198-fold at days 2, 4 and 6 compared 
with the baseline level (day 0), respectively. In addition, Myh 
expression increased by 7,718-, 94,487- and 286,288-fold 
on days 2, 4 and 6 compared with the baseline expression 
level (day 0). Weak positive staining of the cells for H3R protein 
was observed on day 2, whereas highly positive staining was 
observed on days 4 and 6. HR expression during myogenesis 
was, in part, regulated by the stage of differentiation. These 
results along with previous findings indicated possible involve-
ment of H1R in the regulation of progenitor cell mitogenesis and 
of H2R in the relaxation of acetylcholine-stimulated contrac-
tion of muscle cells, following the activation of professional 
histamine-producing cells, including mast cells. By contrast, 
H3R may participate in the regulation of specialized myocyte 
functions, potentially by maintaining the relaxed state under 
the influence of constitutive H3R activity and low histamine 
concentrations, locally produced/released by non-professional 
histamine-producing cells.
Introduction
Histamine is a well-known biogenic and cationic amine, 
which is synthesized, stored and released by professional 
histamine-synthesizing cells. Mast cells, basophils and entero-
chromaffin cells contain the endoplasmic 54 kDa histidine 
decarboxylase (HDC), which converts L-histidine to hista-
mine (1). Histamine is released into and stored within storage 
granules, prior to regulated release (1). Following activation of 
professional histamine-producing cells, a burst release results 
in a transient high histamine concentration in the extracellular 
space. These transient histamine concentrations are sufficient 
to stimulate the conventional histamine receptors, histamine 
receptor type 1 [H1R; binding affinity (pKi) = 4.2] and hista-
mine receptor type 2 (H2R; pKi = 4.3) (2). Smooth muscle 
cells (3,4), cardiomyocytes (5,6) and skeletal muscle tissue (7) 
express these conventional histamine receptors, which regu-
late cellular proliferation and the contraction state of the cells 
stimulated via the histamine/H1R or H2R axes (3-6).
A previous study identified that the cytoplasmic 73 kDa 
‘pro-form’ of HDC produced histamine, however, at a 
100-1,000-fold lower rate compared with the typical enzyme 
isoform of the professional histamine-synthesizing cells (1). 
In non-professional histamine-producing cells, histamine is 
released into the cellular cytoplasm rather than being stored, and 
is therefore not subjected to regulated burst release (8). These 
cells contain organic cation transporters, which are equilibra-
tive uniporters and transport the intracellularly synthesized 
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histamine from the non-professional histamine synthesizing 
cells along the histamine concentration gradient to the extracel-
lular space (8). Histamine concentrations achieved in this manner 
are not sufficient to stimulate conventional histamine receptors. 
Therefore, this mechanism was hypothesized to represent an 
ancestral vestigium of a function that had become obsolete 
during phylogenesis. However, studies conducted within the last 
decade that focus on G-protein coupled receptors have revealed 
novel members of the histamine receptor family (2). These 
novel histamine receptors, histamine receptor type 3 (H3R; 
pKi = 8.0) and histamine receptor type 4 (H4R; pKi = 8.2), have 
>10,000-fold greater affinity for histamine compared with the 
conventional receptors (2). In addition, the low basal levels of 
histamine produced by non-professional histamine-producing 
cells, including dendritic cells (9) and lymphocytes (10,11), 
have been demonstrated to be sufficient in order to bind to and 
regulate cells equipped with these novel, high-affinity hista-
mine receptors. The role of high histamine concentration in 
the regulation of muscle cell tone was investigated in previous 
studies  (3-6). Studies using histamine receptor agonists and/or 
antagonists have suggested that novel histamine receptors may 
also be present and functional in the bronchial smooth muscle 
cells at least (3). However, to date, no studies indicating the pres-
ence of histamine receptors at the messenger RNA (mRNA) and 
protein level in myoblasts, myocytes or myotubes during skel-
etal myogenesis have been reported. Due to the presence and 
role of H1R, H2R and H3R in the function of other muscle cell 
types, the present study aimed to assess whether striated muscle 
cells synthesize and express the histamine receptors, H3R and 
H4R. In addition, the current study investigated whether these 
receptors are developmentally regulated during myogenesis in 
association with various markers of myogenic maturation.
Materials and methods
Cell culture. The present study was approved by the institu-
tional Medical Ethics Committee of the Institue of Clinical 
Medicine, University of Helsinki (Helsinki, Finland) and 
was performed in accordance with the 1983 Declaration 
of Helsinki. Mouse C2C12 myoblasts were obtained from 
the Turku Center for Biotechnology, University of Turku 
(Turku, Finland) (12), and maintained in growth medium 
comprising Dulbecco's modified Eagle's medium (DMEM; 
Lonza/BioWhittaker, Walkersville, MD, USA) supple-
mented with 10% fetal bovine serum (FBS; HyClone, 
GE Healthcare Life Sciences, Little Chalfont, UK), antibi-
otics (100 U/ml penicillin and 100 µg/ml streptomycin; Lonza) 
and 200 mM L‑glutamine (Lonza) at 37˚C in a humidified 
5% CO2 atmosphere. The composition of the differentiation 
medium was similar to the growth medium, with the excep-
tion of FBS, which was reduced from 10% to 1%. The cells 
were passaged using trypsinization (0.5% trypsin in 0.5 mM 
EDTA; Gibco-BRL Life Technologies, Carlsbad, CA, USA) 
from the culture plate at 80% confluence.
Reverse transcription‑quantitative polymerase chain reac‑
tion (RT‑qPCR). To investigate the expression of histamine 
receptors in C2C12 myogenesis, 50,000 cells/well were 
seeded in 12-well plates (CellStar; Greiner Bio-One, 
Frickenhausen, Germany). The cells were initially grown in 
growth medium for two days to reach 80% confluence. Next, 
the medium was exchanged with differentiation medium to 
induce myogenesis. Total RNA was isolated from the cells 
at days 0, 2, 4 and 6 using an RNeasy Mini kit (Qiagen, 
Düsseldorf, Germany) according to the manufacturer's 
instructions. Total RNA (1 µg) was reverse transcribed 
using iScript cDNA Synthesis kit (Bio-Rad Laboratories, 
Inc., Hercules, CA, USA). RT-qPCR was performed with 
100 ng first‑strand cDNA using iQ SYBR® Green Supermix 
(Bio-Rad Laboratories, Inc.) in an iCycler iQ5 Multicolor 
Real-Time PCR Detection system (Bio-Rad Laboratories, 
Inc.). Primers for mouse desmin (Des), myogenin (Myog), 
myosin heavy chain IIa (Myh2), H1R, H2R, H3R, H4R and 
porphobilinogen deaminase (PBGD) genes were designed 
using the National Center for Biotechnology Information 
Primer-Blast tool (Table I; http://www.ncbi.nlm.nih.
gov/tools/primer-blast/; accessed: 01/03/2012). The mRNA 
copy numbers of the samples analyzed were determined in 
triplicate and normalized against the PBGD gene.
Immunofluorescence staining. The C2C12 cells were seeded 
at 2x104 cells/well in 24-well plates (CellStar) on cover-
slips and grown in growth medium for two days to reach 
80% confluence, followed by culturing in differentiation 
Table I. Primer sequences used in reverse transcription-quantitative polymerase chain reaction and the corresponding amplicon 
lengths.
Gene Forward primer Reverse primer Length (bp)
Des 5'-GCCCTCAAGGGCACCAACGA-3' 5'-TTGCTCGGGGCTGGTTTCTCG-3' 297
Myog 5'-CCCAACCAGCGGCTGCCTAA-3' 5'-GTAGGGTCAGCCGCGAGCAA-3' 245
Myh2 5'-AGCTGCACCTTCTCGTTTGCCA-3' 5'-CGGTCAGGGTCGCTCCTGCT-3' 261
H1R 5'-CACTGGAGGCTGCCCTTGTGC-3' 5'-CACCAGCAGGTTGAGGCCCAC-3' 167
H2R 5'-TCCTAAGCGACCCGGTACAGC-3' 5'-ATGGAGACTGAGGCACTGCTGG-3' 208
H3R 5'-TTCGAGCCTCCGCACCCAGAA-3' 5'-GGTCCAACGGCCGGTCAGC-3' 118
H4R 5'-TGCTCAGGTCCCCTTGGCATTT-3' 5'-ACGTGAGGGATGTACAGAGGAATGG-3' 189
PBGD 5'-AAAGTGCCGTGGGAACCAGC-3' 5'-CAGCCACAGCCAGGACGATG-3' 156
Des, desmin; Myog, myogenin; Myh2, myosin heavy chain IIa; HnR, histamine receptor type n (n=1-4); PBGD, porphobilinogen deaminase.
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medium to induce myogenesis. Differentiated cells from 
days 0, 2, 4 and 6 were fixed for 15‑20 min in 4% parafor-
maldehyde (Sigma-Aldrich, St. Louis, MO, USA) with 
phosphate-buffered saline (PBS; 10mM phosphate buffer, 
140 mM saline; pH 7.4), washed three times in PBS (5 min 
each time) and in 0.5% Triton X‑100 (Thermo Fisher Scientific, 
Fair Lawn, NJ, USA)/PBS for 15 min to permeabilize the cells. 
Subsequently, the cells were cultured under the following 
conditions sequentially: i) 10% normal donkey serum (Jackson 
Immunoresearch Laboratories, Inc., West Grove, PA, USA) 
for 1 h; ii) 1 µg/ml polyclonal peptide affinity purified rabbit 
anti-human desmin (1:200), myogenin (1:400) or myosin 
heavy chain (Myh) immunoglobulin G (IgG; 1:400) antibodies 
(obtained from Dr John E. Erikson, University of Turku, 
Turku, Finland) (12), or rabbit anti-human H3R polyclonal 
antibodies (1:1,000; LS-A476; MBL International, Woburn, 
MA, USA) at 4˚C overnight and washed three times in PBS 
(5 min each time). Non-immune rabbit IgG (1:1,000; 1 µg/ml; 
R&D Systems, Minneapolis, MN, USA), was used at the same 
concentration as the primary antibodies as a negative staining 
control; iii) secondary antibody AlexaFluor®488-conjugated 
monoclonal donkey anti-rabbit IgG (1:400; Invitrogen Life 
Technologies, Carlsbad, CA, USA) in 0.1% bovine serum 
albumin (Sigma-Aldrich)-PBS for 1 h and washed three times 
in PBS (5 min each time); iv) DAPI dye (Sigma-Aldrich; 
1:2,000 in distilled water) for 5 min. The coverslips were 
washed twice in PBS and distilled water for 10 min, prior 
to mounting with Vectashield medium (Vector Laboratories, 
Inc., Burlingame, CA, USA). Labeled slides were analyzed 
and photographed using a Leica DM 6000 B/M fluorescence 
microscope, with a motorized Leica XY-stage connected 
to a Leica DFC 420 digital camera, and analyzed using the 
Leica Application Suite Advanced Fluorescence 2.5.0.6735 
software (Leica Microsystems GmbH, Wetzlar, Germany).
Statistical analysis. SPSS software, version 17.0 (SPSS, Inc., 
Chicago, IL, USA) was used to perform statistical analyses 
in addition to Matlab (MathWorks, Inc., Natick, MA, USA), 
which was used to perform the Mann-Whitney U test. All 
values are presented as the mean ± standard error of the 
mean. P<0.05 was considered to indicate a statistically 
significant difference between values.
Results
Myogenesis of C2C12 cells. RT-qPCR was used to detect 
the mRNA expression levels of the early, intermediate and 
late myogenesis markers, desmin, myogenin and Myh2, 
respectively, during differentiation. On day 0, desmin 
was expressed in myoblasts at significantly higher levels 
compared with the myogenin or Myh (Fig. 1A). The desmin 
expression levels increased during myogenesis, reaching 12-, 
68- and 60-fold over the baseline level (day 0), on days 2, 4 
and 6, respectively (Fig. 1B). On day 0, the myogenin mRNA 
exxpression levels were low; however, the mRNA expression 
levels increased by 631-, 1,408- and 914-fold at days 2, 4 
and 6, respectively (Fig. 1C). Desmin and myogenin expres-
sion levels peaked on day 4, whereas the expression of Myh, a 
late myogenesis marker, continued to increase over the entire 
study period, reaching 7,718-, 94,487- and 286,288-fold 
higher expression levels at days 2, 4 and 6, respectively, 
compared with the baseline level (Fig. 1D). 
Indirect immunofluorescence staining of the myogen-
esis marker proteins revealed positive staining of the early 
marker, desmin, at day 0 (Fig. 2A); however, no staining 
was observed for the intermediate marker, myogenin 
(Fig. 2B), or the late marker, Myh (data not shown). On day 2, 
staining for myogenin was found to be positive (Fig. 3A), 
whereas staining for Myh remained negative (Fig. 3B). On 
Figure 1. Myogenesis differentiation marker expression levels, determined by reverse transcription-quantitative polymerase chain reaction. (A) Relative 
expression levels of myogenic differentiation markers desmin (early marker), myogenin (intermediate marker) and Myh (late marker) in C2C12 cells at 
day 0, and relative expression level variations in (B) desmin, (C) myogenin and (D) Myh during myogenesis at days 2, 4 and 6. The data are expressed as the 
mean ± standard deviation. Myh, myosin heavy chain; mRNA, messenger RNA; D, day.
  A   B
  C   D
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days 4 (data not shown) and 6, positive staining for myogenin 
(Fig. 4A) and Myh (Fig. 4B) was detected.
Expression of histamine receptors. RT-qPCR was used to detect 
the mRNA expression levels of histamine receptors associated 
with the differentiation stages (Fig. 5). H1R mRNA was found 
to be highly expressed in C2C12 myoblasts (day 0), whereas 
expression was decreased during the differentiation process 
(Fig. 5A and B). By day 6, the expression level decreased to ~25% 
of the baseline level (day 0). H2R mRNA was also expressed 
in C2C12 cells and the expression levels remained relatively 
constant throughout the differentiation process (Fig. 5A 
and C). The expression of H3R was found to be low in C2C12 
myoblasts; however, following differentiation, the expression 
levels increased by 28-, 103- and 198-fold over the baseline 
level on days 2, 4 and 6, respectively (Fig. 5A and D). H4R 
mRNA expression was not detected at any time-point. 
Indirect immunofluorescence staining for H3R protein 
during the myogenesis of C2C12 cells revealed almost nega-
tive staining at day 0 (Fig. 2C), weakly positive staining on 
day 2 (Fig  3C) and strongly positive staining on days 4 (data 
not shown) and 6 (Fig. 4C).
Figure 3. Immunofluorescent staining (green) of (A) myogenin, (B) myosin heavy chain, (C) histamine receptor type 3 and (D) negative control at day 2 in 
differentiated C2C12 cells. DAPI was used for nuclear counterstaining (blue color). Scale bar, 50 µm.
Figure 2. Immunofluorescent staining (green) of (A) desmin, (B) myogenin, (C) histamine receptor type 3 and (D) negative control at day 0 in undifferentiated 
C2C12 cells. Staining of the late myogenic marker myogenin heavy chain was negative (not shown). DAPI was used for nuclear counterstaining (blue color). 
Scale bar, 50 µm.
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Discussion
To the best of our knowledge, the present study demonstrated 
for the first time that striated muscle cells expressed H1R, 
H2R and H3R-coding mRNA and corresponding receptor 
proteins, but lacked receptor, H4R. The lack of H4R in striated 
muscle cells may be due to the fact that H4R(+) cells have been 
previously been identified in the bone marrow, thymus and 
spleen, as well as at the cellular level in bone marrow-derived 
cells, including mast cells, basophils, eosinophils, neutrophils, 
dendritic cells and lymphocytes (13). 
Investigation of the early, intermediate and late phases of 
myogenesis was performed using desmin, myogenin and Myh 
as markers, respectively. The results indicated that histamine 
receptors were dynamically regulated during differentiation, 
suggesting that they may have distinct regulatory functions. 
H1R presented the highest expression in myoblasts on day 0, 
compared with the other receptors; however, the expression 
levels of H1R were subsequently decreased during myogenesis. 
Figure 4. Immunofluorescent staining (green) of (A) myogenin, (B) myosin heavy chain, (C) histamine receptor type 3 and (D) negative control at day 6 in 
differentiated C2C12 cells. DAPI was used as a nuclear counterstain (blue color). Scale bar, 50 µm.
Figure 5. Histamine receptor subtype expression levels, determined by reverse transcription-quantitative polymerase chain reaction. (A) Relative expression 
levels of H1R, H2R and H3R in C2C12 cells at day 0, and relative expression level variations of (B) H1R, (C) H2R and (D) H3R during myogenesis (days 0-6). 
The data are expressed as the mean ± standard deviation. mRNA, messenger RNA; HnR, histamine receptor type n (where n=1, 2 or 3).
  A   B
  C   D
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H2R expression was found to be low on day 0 and remained 
relatively constant throughout all the phases of myogenesis. 
By contrast, H3R showed the lowest expression in myoblasts 
on day 0; however, the H3R expression levels were subse-
quently increased, and continued to increase throughout 
myogenesis.
The low affinity of H1Rs for histamine requires burst 
release from professional histamine-synthesizing cells in 
order to induce target cell effects. Notably, in cardiomyocyte 
precursor cells, H1Rs are abundant and regulate Ca2+ oscilla-
tion and frequency. In such progenitor cells, this process is 
coupled with the entry of cells into the cell cycle and bromode-
oxyuridine incorporation (5). The results of the present study, 
which revealed high levels of H1R expression during early 
myogenesis, along with the aforementioned previous obser-
vations, suggested that high histamine levels may stimulate 
myoblast proliferation during the early phases of differentia-
tion. This hypothesis is further supported by the observations 
of a previous study, which demonstrated that mast cell precur-
sors migrated from bone marrow to skeletal muscle tissue in 
17 to 20-day-old rat fetuses, indicating interactions between 
the professional histamine-producing mast cells and skeletal 
muscle cells in proliferation or differentiation (14). 
In the present study, H2R expression remained constant 
throughout all the phases of myogenesis, and thus, may be 
involved in the maintenance of relaxation following burst 
release of histamine (since H2R stimulation requires high 
histamine concentrations), with a curare-like effect (which 
is a competitive antagonist of the nicotinic acetylcholine 
receptor) (15). By contrast, H2R antagonists have been demon-
strated to possess an anti-cholinesterase activity (16).
Due to the high affinity of H3R for histamine, the 
non-professional histamine-producing cells are able to stimu-
late H3R-expressing cells. The levels of histamine released by 
the non‑professional histamine‑producing cells are not suffi-
cient to activate the conventional, low‑affinity receptors (2). 
Furthermore, in contrast to the conventional H1R and H2R, H3R 
has a relatively high constitutive activity level, which is ~25% 
active in the absence of H3R-ligands (17,18). According to the 
two-state model of receptor activation, G-protein coupled 
receptors exist in equilibrium between an active and inactive 
receptor state. Upon ligand binding, the G-protein becomes 
activated (R*) and begins to ‘couple’ and transduce the extra-
cellular stimulus into an intracellular signal, while ligand-free 
G-protein coupled receptors exist in a passive, uncoupled 
conformation. However, H3R spontaneously acquires the R* 
state, which promotes G-protein-mediated signaling in the 
absence of an agonist. Therefore, H3R is hypothesized to have 
significant constitutive functions in mature myocytes and 
myotubes, which are independent of burst release (cellular 
emergencies) and driven by the low histamine concentrations 
generated by non-professional histamine-producing cells and 
by their constitutive activity (17,18).
High histamine concentrations are known to mediate the 
pathological contraction of smooth muscles cells in the bron-
chiolar walls, including during acute attacks of asthma and 
anaphylactic reactions mediated by H1R. H1R is coupled to Gαq/11 
protein, which cleaves phosphatidylinositol 4,5-bisphosphate to 
diacylglycerol and inositol 1,4,5-trisphosphate, via the activa-
tion of phospholipase C. This results in Ca2+ influx and initiates 
smooth muscle contraction (3). Notably, low histamine concen-
trations act as potent relaxant agents for pre-contracted smooth 
muscle cells via H3Rs (3). In the present study, the time course 
of H3R expression during myogenesis indicated that H3R may 
have long-term, constitutive effects on mature skeletal muscles 
cells, rather than being activated under exceptional circum-
stances that results in burst release of the histamine stores from 
mast cells and basophils. Based on the findings of Cardell and 
Edvinsson (3) and the long-term low histamine level-induced 
and constitutive H3R function, H3R was hypothesized to main-
tain the relaxed state of mature skeletal muscle cells.
In conclusion, further studies are required in order to 
determine the functions and potential signalling pathways by 
which the expression of the three histamine receptor subtypes, 
examined in the present study, are regulated during myogenesis 
in skeletal muscle cells. Future research may elucidate novel 
information regarding the etiology and potential treatment of 
skeletal muscle diseases.
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